Cargando…

Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity

Beta-lactams are an important family of antibiotics used to treat infections and are commonly used in critically ill patients. Optimal use of these drugs in the intensive care unit (ICU) is important because of the serious complications from sepsis. Target beta-lactam antibiotic exposures may be cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legg, Amy, Carmichael, Sinead, Chai, Ming G., Roberts, Jason A., Cotta, Menino O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215385/ https://www.ncbi.nlm.nih.gov/pubmed/37237773 http://dx.doi.org/10.3390/antibiotics12050870

Ejemplares similares

What Are the Current Approaches to Optimising Antimicrobial Dosing in the Intensive Care Unit?
por: Chai, Ming G., et al.
Publicado: (2020)

Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?
por: Roger, Claire, et al.
Publicado: (2021)

International survey of antibiotic dosing and monitoring in adult intensive care units
por: Williams, Paul G., et al.
Publicado: (2023)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)

Beta-lactam allergy labeling in intensive care units: An observational, retrospective study
por: Leone, Marc, et al.
Publicado: (2021)

Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software
por: Roberts, Jason A., et al.
Publicado: (2022)

Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units
por: Matusik, Elodie, et al.
Publicado: (2022)

Beta-lactam antibiotic test doses in the emergency department
por: Maguire, Michelle, et al.
Publicado: (2020)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Comparison of acute kidney injury and clinical prognosis of vancomycin monotherapy and combination therapy with beta-lactams in the intensive care unit
por: Kang, Soyoung, et al.
Publicado: (2019)

Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics
por: Cloesmeijer, Michael E., et al.
Publicado: (2020)

2545. Impact of Early Dose Adjustment of Beta-Lactams in Patient with Septic Shock
por: Tawwater, John C, et al.
Publicado: (2023)

24/7 Therapeutic Drug Monitoring of Beta-Lactam Antibiotics with CLAM-2000
por: Khromov, Tatjana, et al.
Publicado: (2023)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

Comment: Is off-label medication use in the ICU a problem?
por: Cotta, Menino O., et al.
Publicado: (2023)

1825. Optimizing β-lactam Therapy in Surgical Intensive Care Unit Patients Using Therapeutic Drug Monitoring
por: Al-Shaer, Mohammad H, et al.
Publicado: (2019)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

Endopeptidase-Mediated Beta Lactam Tolerance
por: Dörr, Tobias, et al.
Publicado: (2015)

Profile of Enterobacteria Resistant to Beta-Lactams
por: Santos, Andressa Liberal, et al.
Publicado: (2020)

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’
por: Dhaese, Sofie A. M., et al.
Publicado: (2022)

Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies
por: Gastine, Silke, et al.
Publicado: (2021)

The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
por: Pai Mangalore, Rekha, et al.
Publicado: (2023)

743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
por: Ausman, Sara, et al.
Publicado: (2022)

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2017)

Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs
por: Connelly, Sheila, et al.
Publicado: (2019)

Diagnostic and medical needs for therapeutic drug monitoring of antibiotics
por: Mabilat, Claude, et al.
Publicado: (2019)

THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective
Publicado: (1980)

Beta-lactam hypersensitivity: not always what it seems
por: Andrade, Djanira, et al.
Publicado: (2015)

Use of beta-lactams antibiotics in ICU patients
por: Damas, M-P, et al.
Publicado: (2015)

Dual beta-lactam treatment: Pros and cons
por: Guerra, Diogo, et al.
Publicado: (2022)

Approach for delabeling beta-lactam allergy in children
por: Sáenz de Santa María, R., et al.
Publicado: (2023)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case–Control Study
por: Naciri, Tayma, et al.
Publicado: (2022)

The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
por: Novy, Emmanuel, et al.
Publicado: (2023)

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
por: Barreto, Erin F., et al.
Publicado: (2021)

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units
por: Weinelt, Ferdinand Anton, et al.
Publicado: (2021)

Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rg3s63eftk11blp1tb3qb50fts